ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective Study

ABSTRACT Purpose Systemic treatment options for vulvar squamous cell carcinoma (VSCC) are limited. ROS1, a tyrosine kinase implicated, for example, in non‐small cell lung cancer (NSCLC), has recently shown responsiveness to tyrosine kinase inhibitors. This study investigated immunohistochemical ROS1...

全面介紹

書目詳細資料

Principais autores:	Meletios P. Nigdelis, Annick Bitterlich, Mariam Parvanta, Bashar Haj Hamoud, Erich Franz Solomayer, Martin Ertz, Laura Schnöder, Annette Hasenburg, Bernd Holleczek, Mathias Wagner, Gilbert Georg Klamminger
格式:	Artigo
語言:	Inglês
出版:	Wiley 2025-08-01
叢編:	Cancer Medicine
主題:	immunohistochemistry ROS1 tyrosine kinase inhibitors vulvar cancer
在線閱讀:	https://doi.org/10.1002/cam4.71160
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!